Valeant Returns $1bn Female Libido Drug For Free

At first glance, giving back Addyi to the original owners for next to nothing looks like a complete disaster but investors are relieved debt-ridden Valeant has managed to offload another asset.

Money down drain
Valeant's acquisition of Sprout was not money well-spent • Source: Shutterstock

More from Deals

More from Business